Chien-Shing Chen, MD, PHD
Prior to joining Jiahui Health as Executive Director of Cancer Center, Dr. Chen was Professor of Medicine and Basic Science; Chief, Division of Medical Oncology & Hematology over 10 years and Bessie Emanuel Endowed Chair for Clinical Oncology Research at Loma Linda University and Medical Center, California, USA. In addition to multiple leadership roles in stem cell transplant, heme/oncology fellowship and biospecimen bank program development as well as mentoring oncology fellows and residents, Dr. Chen was the primary investigator for multiple clinical research trials and translational research including malignant hematology and solid tumors, and has published more than 65 peer-reviewed papers in PNAS, Leukemia, Blood, Oncogene, Cancer Research, and Journal of Clinical Oncology.
Dr. Chen graduated from China Medical University, Taiwan and completed Ph.D. and postdoctoral training in molecular oncology (Pathobiology Program) at University of Minnesota, USA. He received his Internal Medicine internship and residency training at the Washington University Medical Center, Barnes Hospital in St Louis, Missouri followed by Medical Oncology fellowship at Fred Hutchinson Cancer Research Center (FHCRC) and University of Washington in Seattle.
In clinical practice, Dr. Chen is licensed to practice in California, U.S. and China, and specialized in lymphoma, myeloma, leukemia, stem cell transplant, and driver mutation targeted therapy in cancers.
Dr. Chen is double board-certified by the American Board of Internal Medicine (ABIM) in Internal Medicine and Medical Oncology.
陈博士出任嘉会医疗肿瘤中心执行总监之前，曾任美国加利福尼亚州洛马林达大学医学及基础科学教授, 博士班导师，及洛马林达大学医院肿瘤内科与血液学科主任逾10年，也曾被授予临床肿瘤学研究Bessie Emanuel讲座医学教授。其主导规划临床教学课程，指导博士班, 肿瘤专科医师和住院医师，此外也是恶性血液学和实体瘤等多项临床及转化医学研究的项目主导者， 迄今于PNAS、Leukemia、Blood、Cancer Research、Oncogene、Journal of Clinical Oncology等国际核心期刊发表65篇以上同行评议论文。
陈建行博士毕业于台湾中国医药大学医学系, 于美国明尼苏达大学获得博士学位(PHD)，完成分子肿瘤学（病理学课程）博士后培训，之后在美国密苏里州圣刘易斯华盛顿大学医学中心Barnes医院完成内科实习和住院医师培训，在Fred Hutchinson癌症研究中心（FHCRC）和西雅图华盛顿大学完成肿瘤内科专科培训。